secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2025-05-29T23:59:59+00:00
Accession:  0001558370-25-008245
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRadimed receives FDA 510(k) clearance for next-gen MRidium 3870 infusion pump
------------------------------------------------------------------------------

- FDA granted 510(k) clearance on May 29, 2025 for the MRidium 3870 IV Infusion Pump System.
- Company remains the world's only supplier of non-magnetic MRI infusion pump devices (first device in 2005).
- New pump features enhanced touchscreen UI, advanced safety, drug library, and four-channel capability.
- Strategic rollout begins with initial units in Q4 2025; full commercial distribution ramps through 2026.
- CEO Roger Susi says clearance is a milestone from FDA collaboration on evolving regulatory requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025008245/0001558370-25-008245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025008245/irmd-20250529x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-008245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer